⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INMB News
INmune Bio Inc. Common stock
INmune Bio to Present Positive Phase 2 Imaging Data for XPro in Early Alzheimer’s Disease at AAIC
globenewswire.com
INMB
Form 8-K
sec.gov
INMB
INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion
globenewswire.com
INMB
INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™
globenewswire.com
INMB
Form 8-K
sec.gov
INMB
INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB
globenewswire.com
INMB
Form 8-K
sec.gov
INMB
Form 8-K
sec.gov
INMB
INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial
globenewswire.com
INMB
Three TriKE Candidates In Clinic As NK Cell Engager Field Reorganizes
prnewswire.com
NKTX
GTBP
IBRX
FATE
INMB